Xagenic Hosts CLIA Waiver Panel Discussion At The Molecular Med Tri-Con 2015

Xagenic, a molecular diagnostics company developing the lab-free Xagenic X1™ system designed to inform real-time treatment decisions, today announced that the Company will lead a panel discussing the intricacies of a CLIA waiver for near-patient, point of care diagnostic systems at the Molecular Med Tri-Con 2015, February 15-20 at the Moscone North Convention Center in San Francisco.

Help employers find you! Check out all the jobs and post your resume.